was read the article
array:24 [ "pii" => "S0185106316300166" "issn" => "01851063" "doi" => "10.1016/j.hgmx.2016.04.006" "estado" => "S300" "fechaPublicacion" => "2017-01-01" "aid" => "75" "copyright" => "Sociedad Médica del Hospital General de México" "copyrightAnyo" => "2016" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "ssu" "cita" => "Rev Med Hosp Gen Mex. 2017;80:60-6" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2083 "formatos" => array:3 [ "EPUB" => 54 "HTML" => 1693 "PDF" => 336 ] ] "itemSiguiente" => array:19 [ "pii" => "S0185106316301007" "issn" => "01851063" "doi" => "10.1016/j.hgmx.2016.08.009" "estado" => "S300" "fechaPublicacion" => "2017-01-01" "aid" => "126" "copyright" => "Sociedad Médica del Hospital General de México" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "ssu" "cita" => "Rev Med Hosp Gen Mex. 2017;80:67-70" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1692 "formatos" => array:3 [ "EPUB" => 35 "HTML" => 1233 "PDF" => 424 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review article</span>" "titulo" => "Remifentanil and dexmedetomidine as an alternative to regional analgesia in obstetrics" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "67" "paginaFinal" => "70" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Remifentanil y dexmedetomidina como alternativa a la analgesia regional para analgesia obstétrica" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1345 "Ancho" => 3109 "Tamanyo" => 108353 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Chemical structure of remifentanil.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M. Aguilar-Montiel, O. Carrillo-Torres" "autores" => array:2 [ 0 => array:2 [ "nombre" => "M." "apellidos" => "Aguilar-Montiel" ] 1 => array:2 [ "nombre" => "O." "apellidos" => "Carrillo-Torres" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0185106316301007?idApp=UINPBA00004N" "url" => "/01851063/0000008000000001/v2_201702120003/S0185106316301007/v2_201702120003/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S0185106316300683" "issn" => "01851063" "doi" => "10.1016/j.hgmx.2016.06.006" "estado" => "S300" "fechaPublicacion" => "2017-01-01" "aid" => "105" "copyright" => "Sociedad Médica del Hospital General de México" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "Rev Med Hosp Gen Mex. 2017;80:56-9" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1543 "formatos" => array:3 [ "EPUB" => 66 "HTML" => 1180 "PDF" => 297 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Clinical case</span>" "titulo" => "First published case of thoracoscopic patent ductus arteriosus closure in the general hospital of Mexico Dr. Eduardo Liceaga" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "56" "paginaFinal" => "59" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Primer caso publicado de cierre toracoscópico de persistencia de conducto arterioso en el Hospital General de México Dr. Eduardo Liceaga" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0025" "etiqueta" => "Figure 5" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr5.jpeg" "Alto" => 714 "Ancho" => 1196 "Tamanyo" => 83973 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Incisions 20<span class="elsevierStyleHsp" style=""></span>h after surgical procedure.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "W.L. Dajer-Fadel, M.G. Pliego-Sánchez, E.M. Mejía-Melgar, D.P. Yépez-Ramos, C.A. Latorre-Davila, C.R. Tortolero-Sánchez, O. Flores-Calderón, S. Ramírez-Castañeda, O.F. López-Noria, R. Argüero-Sánchez" "autores" => array:10 [ 0 => array:2 [ "nombre" => "W.L." "apellidos" => "Dajer-Fadel" ] 1 => array:2 [ "nombre" => "M.G." "apellidos" => "Pliego-Sánchez" ] 2 => array:2 [ "nombre" => "E.M." "apellidos" => "Mejía-Melgar" ] 3 => array:2 [ "nombre" => "D.P." "apellidos" => "Yépez-Ramos" ] 4 => array:2 [ "nombre" => "C.A." "apellidos" => "Latorre-Davila" ] 5 => array:2 [ "nombre" => "C.R." "apellidos" => "Tortolero-Sánchez" ] 6 => array:2 [ "nombre" => "O." "apellidos" => "Flores-Calderón" ] 7 => array:2 [ "nombre" => "S." "apellidos" => "Ramírez-Castañeda" ] 8 => array:2 [ "nombre" => "O.F." "apellidos" => "López-Noria" ] 9 => array:2 [ "nombre" => "R." "apellidos" => "Argüero-Sánchez" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0185106316300683?idApp=UINPBA00004N" "url" => "/01851063/0000008000000001/v2_201702120003/S0185106316300683/v2_201702120003/en/main.assets" ] "en" => array:19 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review article</span>" "titulo" => "Brain metastases: Literature review" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "60" "paginaFinal" => "66" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "J.L. Navarro-Olvera, E. Ariñez-Barahona, M.A. Esqueda-Liquidano, A. Muñoz-Cobos" "autores" => array:4 [ 0 => array:4 [ "nombre" => "J.L." "apellidos" => "Navarro-Olvera" "email" => array:1 [ 0 => "luiginavarro97@hotmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "E." "apellidos" => "Ariñez-Barahona" ] 2 => array:2 [ "nombre" => "M.A." "apellidos" => "Esqueda-Liquidano" ] 3 => array:2 [ "nombre" => "A." "apellidos" => "Muñoz-Cobos" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Neurology and Neurosurgery Service, Neurosurgery Department, Hospital General de México “Dr. Eduardo Liceaga”, Mexico City, Mexico" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Enfermedad metastásica cerebral: revisión de la literatura" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 816 "Ancho" => 1501 "Tamanyo" => 133739 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Axial cut of contrast MRI of the brain. On the left, T2-weighted image showing hyperintense left frontal region marked with arrows. On the right, T1-weighted image showing perilesional hypointensity and central hyperintensity of the left frontal region marked with arrows.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">The real incidence of metastatic brain tumours remains unknown,<a class="elsevierStyleCrossRefs" href="#bib0200"><span class="elsevierStyleSup">1,2</span></a> although some countries such as the United States of America report 17,000 cases annually,<a class="elsevierStyleCrossRef" href="#bib0200"><span class="elsevierStyleSup">1</span></a> and some authors consider brain metastases such as intracranial tumour to be more common.</p><p id="par0010" class="elsevierStylePara elsevierViewall">Brain metastases occur in 15–40% of patients with systemic cancer, which represents approximately 12 patients per 100,000 inhabitants per year.<a class="elsevierStyleCrossRefs" href="#bib0210"><span class="elsevierStyleSup">3–5</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">It is usually diagnosed between the 5th and 7th decade of life. This concurs with statistics from the American Cancer Society, which reveal that the probability of developing invasive cancer is high between 60 and 79 years of age.<a class="elsevierStyleCrossRef" href="#bib0225"><span class="elsevierStyleSup">6</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">Even after performing a thorough study to identify the primary tumour, it remains undetected in 15% of patients.<a class="elsevierStyleCrossRef" href="#bib0230"><span class="elsevierStyleSup">7</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">Certain types of cancers are more prone to spread to the central nervous system.<a class="elsevierStyleCrossRef" href="#bib0235"><span class="elsevierStyleSup">8</span></a> The most common, in order of frequency, are lung cancer, breast cancer, melanoma, colorectal and renal cancer, and less frequently thyroid cancer, gastrointestinal cancer and prostate cancer. Haematological neoplasms constitute only 10% of brain metastases and primarily affect the leptomeninges<a class="elsevierStyleCrossRefs" href="#bib0240"><span class="elsevierStyleSup">9–11</span></a> (see <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>).</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Clinical diagnosis</span><p id="par0030" class="elsevierStylePara elsevierViewall">Most patients’ initial manifestations are neurological, and therefore their first point of contact is commonly with a neurosurgeon or neurologist before they are referred to an oncologist.<a class="elsevierStyleCrossRef" href="#bib0255"><span class="elsevierStyleSup">12</span></a> It is considered that 15% of patients in whom the primary tumour has been identified at the time of diagnosis and 45% of these who moreover present neurological symptoms will be diagnosed with metastatic brain tumour.<a class="elsevierStyleCrossRefs" href="#bib0260"><span class="elsevierStyleSup">13,31</span></a></p><p id="par0035" class="elsevierStylePara elsevierViewall">The most common symptoms include (see <a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>) headache, weakness, alterations of higher brain functions, focal neurological deficit and seizures, which are caused due to a local mass, cerebral oedema and increased intracranial pressure.<a class="elsevierStyleCrossRef" href="#bib0265"><span class="elsevierStyleSup">14</span></a></p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Diagnostic imaging</span><p id="par0040" class="elsevierStylePara elsevierViewall">Nuclear magnetic resonance imaging (MRI) of the brain is considered to be the exam of choice in patients with clinical suspicion of brain metastasis because it has a high sensitivity and specificity.<a class="elsevierStyleCrossRef" href="#bib0270"><span class="elsevierStyleSup">15</span></a></p><p id="par0045" class="elsevierStylePara elsevierViewall">Nevertheless, in patients with a contraindication for MRI, computed axial tomography (CAT) scan of the brain or PET (positron emission tomography) are the favoured options. CAT scan of the brain can be performed with or without a contrast medium to reveal metastatic lesions that are isodense to the brain parenchyma (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>), whilst a hyperdense image suggests the presence of haemorrhage, which could lead to the diagnosis of lung tumour, renal tumour, thyroid tumour, choriocarcinoma or melanoma metastasis. Moreover, it determines whether the patient has hydrocephalus, brain oedema or brain herniation. When a contrast medium is administered the lesion is enhanced and multiple lesions become visible.<a class="elsevierStyleCrossRefs" href="#bib0275"><span class="elsevierStyleSup">16,17,26</span></a></p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0050" class="elsevierStylePara elsevierViewall">MRI of the brain employs basic T1- and T2-weighted sequences, FLAIR, diffusion and perfusion, in addition to spectroscopy and tractography. Most metastatic lesions are hypointense on T1-weighted images, which could be indicative of haemorrhage, melanin and necrosis (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>). On T2-weighted images most lesions are hyperintense. Bleeding appears as hypointense when in acute state, and hyperintense when subacute, while vasogenic oedema is hyperintense.<a class="elsevierStyleCrossRef" href="#bib0285"><span class="elsevierStyleSup">18</span></a> Spectroscopy is a magnetic resonance imaging technique that enables the metabolic characteristics of the lesion to be evaluated. It can be represented in 2D (two dimensional) or 3D (three dimensional) (<a class="elsevierStyleCrossRef" href="#fig0015">Fig. 3</a>), detecting the ranges of spectra of normal brain tissue, metastasis, necrosis, gliosis and vasogenic oedema.<a class="elsevierStyleCrossRefs" href="#bib0290"><span class="elsevierStyleSup">19,20</span></a> PET and SPECT (single-photon emission computed tomography) used for the diagnosis of brain metastasis are limited, due to their low sensitivity for detecting small lesions or potentially recurring tumours, and PET is limited to differentiating between necrosis due to radiation or recurrence.<a class="elsevierStyleCrossRefs" href="#bib0300"><span class="elsevierStyleSup">21,22</span></a> Complementary studies such as chest–abdomen–pelvis CT scan, chest X-ray, bronchoscopy, CARBOWAX and tumour markers are conducted according to the clinical suspicion of the disease.</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia><elsevierMultimedia ident="fig0015"></elsevierMultimedia><p id="par0055" class="elsevierStylePara elsevierViewall">The use of brain resonance is recommended as part of the evaluation for some patients with tumours that have already been diagnosed, those on treatment and those in follow-up.<a class="elsevierStyleCrossRef" href="#bib0305"><span class="elsevierStyleSup">22</span></a></p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Stereotactic biopsy for the diagnosis of metastatic brain tumours</span><p id="par0060" class="elsevierStylePara elsevierViewall">For multiple lesions located deep in the brain or in highly specialised regions (language area, primary motor area, visual area) and when the primary tumour has not been identified in other studies, stereotactic biopsy is a valuable diagnostic resource, with a mortality rate of less than 1% (<a class="elsevierStyleCrossRef" href="#fig0020">Fig. 4</a>).</p><elsevierMultimedia ident="fig0020"></elsevierMultimedia></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">RPA (recursive partitioning analysis) classification</span><p id="par0065" class="elsevierStylePara elsevierViewall">The RTOG (Radiation Therapy Oncology Group) developed a statistical method to categorise cancer patients, called the RPA classification system. It contemplates several factors such as patient age, Karnofsky Performance Status (KPS) and control of primary tumour, to better understand the prognostic factors for selecting patients who will benefit from surgery. Patients with RPA class 1 are under 65 years of age, with a KPS greater than 70% and control or absence of systemic disease. RPA class 2 patients are older than 65 years of age with a KPS greater than 70% and uncontrolled systemic disease. RPA class 3 patients have a KPS under 70%.</p><p id="par0070" class="elsevierStylePara elsevierViewall">RPA class 1 patients are considered to be good candidates for craniotomy and resection, while RPA class 3 patients are the worst candidates for surgical treatment. The selection of RPA class 2 patients is less clear, requiring survival time and medical risk factors for surgery to be taken into account.<a class="elsevierStyleCrossRef" href="#bib0310"><span class="elsevierStyleSup">23</span></a></p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Treatment</span><p id="par0075" class="elsevierStylePara elsevierViewall">Treatment consists of surgery, radiotherapy, radiosurgery, chemotherapy and drugs such as antiepileptics and corticosteroids. Antiepileptic drugs, such as phenytoin (DPH) at a starting dose of 15–17<span class="elsevierStyleHsp" style=""></span>mg/kg and a sustained dose of 5–7<span class="elsevierStyleHsp" style=""></span>mg/kg, have been shown to be prophylactic treatment for generalised seizures, and other anticonvulsants have been used for focal seizures, such as carbamazepine or oxcarbazepine.<a class="elsevierStyleCrossRef" href="#bib0315"><span class="elsevierStyleSup">24</span></a> The corticosteroid of choice in the management of vasogenic cerebral oedema is dexamethasone, recommended for moderate symptoms at a dose of 4–8<span class="elsevierStyleHsp" style=""></span>mg/day. For severe symptoms the dose may be increased up to 16<span class="elsevierStyleHsp" style=""></span>mg/day, with a duration of treatment no longer than 2 weeks.<a class="elsevierStyleCrossRef" href="#bib0320"><span class="elsevierStyleSup">25</span></a></p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Surgery</span><p id="par0080" class="elsevierStylePara elsevierViewall">It provides different advantages over other treatments: firstly, complete resection immediately removes the mass effect, brain irritation and vasogenic cerebral oedema; secondly, surgery provides tissue to be sent for histopathological study in case the primary tumour is unknown; and thirdly, complete surgical resection provides local cure.<a class="elsevierStyleCrossRefs" href="#bib0330"><span class="elsevierStyleSup">27,28</span></a> Occasionally the risks of surgery exceed the benefits, such as: secondary neurological deficit due to lesion in an eloquent area, meningitis, brain abscess, intracranial haemorrhage or even death. Nevertheless, thanks to modern techniques and sophisticated technology, surgical mortality for brain metastases has dramatically decreased since the initial reports of craniotomies, and is now below 3%. The risk of haemorrhage or neurological deterioration associated with surgery is less than 5%, while the risk of meningitis and brain abscess is less than 1%. Non-surgery-related complications, such as infection, deep vein thrombosis, pulmonary embolism and pneumonia, occur in 8–10% of patients.<a class="elsevierStyleCrossRefs" href="#bib0335"><span class="elsevierStyleSup">28–30</span></a></p><p id="par0085" class="elsevierStylePara elsevierViewall">Treatment protocols have been defined for single and multiple brain metastases, from which the following can be concluded: Patients with systemic disease and single brain metastasis should be treated with surgical resection plus whole brain radiotherapy. This has led to an increase in survival, fewer recurrences and greater quality of life.<a class="elsevierStyleCrossRef" href="#bib0360"><span class="elsevierStyleSup">33</span></a> Patients with three lesions or fewer, with good systemic control, should also be treated with surgery and whole brain radiotherapy, as the outcome is the same as for patients treated for single metastasis.<a class="elsevierStyleCrossRef" href="#bib0355"><span class="elsevierStyleSup">32</span></a> Despite advances in surgery and the safety of the anaesthesia technique, patients with more than three lesions have a particularly poor prognosis and are not good candidates for surgery. Data obtained from several retrospective studies show that for patients with controlled systemic disease and more than three surgically accessible lesions, surgical intervention should be discussed with a good neuro-oncology team.<a class="elsevierStyleCrossRef" href="#bib0360"><span class="elsevierStyleSup">33</span></a></p><p id="par0090" class="elsevierStylePara elsevierViewall">The management of recurring metastases should be as per the most recent references similar to the newly diagnosed brain metastasis, as it is considered to have the same outcome.<a class="elsevierStyleCrossRef" href="#bib0365"><span class="elsevierStyleSup">34</span></a></p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Radiotherapy</span><p id="par0095" class="elsevierStylePara elsevierViewall">The optimal dose for managing patients with brain metastasis includes 10 sessions of 3<span class="elsevierStyleHsp" style=""></span>Gy (30<span class="elsevierStyleHsp" style=""></span>Gy) split over two weeks or 15 sessions of 2.5<span class="elsevierStyleHsp" style=""></span>Gy (37.5<span class="elsevierStyleHsp" style=""></span>Gy) split over three weeks. These variations in dose and time have not demonstrated superior results; in fact, dose and time increases have been shown to cause more adverse effects.</p><p id="par0100" class="elsevierStylePara elsevierViewall">Complications caused by radiotherapy are classified as acute (under 90 days) and chronic (more than 90 days). Acute complications include hair loss, dermatitis, otitis externa, hearing loss, nausea, vomiting and drowsiness. Chronic complications include tissue necrosis, personality changes, memory loss, cerebellar disorders, cataracts and deterioration in cognitive function.<a class="elsevierStyleCrossRef" href="#bib0370"><span class="elsevierStyleSup">35</span></a></p></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Radiosurgery</span><p id="par0105" class="elsevierStylePara elsevierViewall">The main candidates for this treatment are those patients who do not meet the criteria for surgical treatment, those with lesions under 3<span class="elsevierStyleHsp" style=""></span>cm or lesions located in eloquent areas, and those with residual lesion after resection. The treatment parameters imply that the maximum tolerated dose depends on the diameter of the lesion: 15<span class="elsevierStyleHsp" style=""></span>Gy for tumours under 20<span class="elsevierStyleHsp" style=""></span>mm and 20<span class="elsevierStyleHsp" style=""></span>Gy for tumours 31–40<span class="elsevierStyleHsp" style=""></span>mm.<a class="elsevierStyleCrossRefs" href="#bib0375"><span class="elsevierStyleSup">36,37</span></a></p></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Chemotherapy</span><p id="par0110" class="elsevierStylePara elsevierViewall">The role of chemotherapy in the treatment of patients with brain metastasis is not clearly defined. Currently, chemotherapy is used very little in the management of patients not included in research protocols, with the exception of very chemo-sensitive tumours, such as small cell lung carcinoma, germ cell tumours and lymphoid neoplasms.<a class="elsevierStyleCrossRef" href="#bib0385"><span class="elsevierStyleSup">38</span></a></p></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Prognosis</span><p id="par0115" class="elsevierStylePara elsevierViewall">The prognosis of brain metastasis patients in the last two decades with the use of combined therapies shows an increase in survival compared to patients who only received radiotherapy or surgery. The final result of the studies conducted shows that surgery plus radiotherapy presents an increase in survival of 7–9 months.<a class="elsevierStyleCrossRefs" href="#bib0320"><span class="elsevierStyleSup">25,29,39</span></a></p></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Dural metastases</span><p id="par0120" class="elsevierStylePara elsevierViewall">These usually affect patients at advanced disease stages and the mechanisms of dissemination are direct extension or haematogenous spread.</p><p id="par0125" class="elsevierStylePara elsevierViewall">The incidence of dural metastases has increased in recent decades as a result of developments in new neuroimaging techniques and an increase in the survival of cancer patients due to improved therapies. Most patients are asymptomatic; however, they may debut with progressive neurological deficit.<a class="elsevierStyleCrossRefs" href="#bib0360"><span class="elsevierStyleSup">33,34</span></a> The most recent study in the literature review was published by Laigle-Donadey, covering 198 cases from 1994 to 2003. The patient age range was from 4 months to 84 years (mean of 59 years) and the most common dural metastases reported (in order of frequency) were prostate, breast, lung and stomach cancer, making up 54.5% (108 patients). The exact incidence of dural metastases is difficult to ascertain<a class="elsevierStyleCrossRef" href="#bib0390"><span class="elsevierStyleSup">39</span></a> (see <a class="elsevierStyleCrossRef" href="#tbl0015">Table 3</a>).</p><elsevierMultimedia ident="tbl0015"></elsevierMultimedia></span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Clinical manifestations</span><p id="par0130" class="elsevierStylePara elsevierViewall">The symptoms presented are usually related to brain compression or invasion, production of subdural haematomas or fluid collection, and less frequently due to occlusion of branches to the dural sinuses. Approximately 20% of patients are asymptomatic, and the lesions are identified in a follow-up study or in necropsy<a class="elsevierStyleCrossRef" href="#bib0385"><span class="elsevierStyleSup">38</span></a> (see <a class="elsevierStyleCrossRef" href="#tbl0020">Table 4</a>).</p><elsevierMultimedia ident="tbl0020"></elsevierMultimedia><p id="par0135" class="elsevierStylePara elsevierViewall">Non-traumatic subdural haematomas resulting from neoplastic invasion of the meninges are a classic complication, with an incidence observed in 15–40% of cases.<a class="elsevierStyleCrossRefs" href="#bib0380"><span class="elsevierStyleSup">37,38</span></a></p></span><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Diagnosis</span><p id="par0140" class="elsevierStylePara elsevierViewall">The exam of choice is contrast-enhanced MRI of the brain (<a class="elsevierStyleCrossRef" href="#fig0025">Fig. 5</a>). The classic image of dural metastasis is a mass with homogeneous enhancement on T2-weighted images, originating in the dura mater. When the dural tail sign appears, a differential diagnosis should be made for meningioma, particularly in patients with prostate cancer, which also causes a hyperostotic effect.<a class="elsevierStyleCrossRef" href="#bib0375"><span class="elsevierStyleSup">36</span></a></p><elsevierMultimedia ident="fig0025"></elsevierMultimedia></span><span id="sec0075" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Treatment</span><p id="par0145" class="elsevierStylePara elsevierViewall">Surgical resection is normally performed when there is a single, well defined lesion that is surgically accessible, with adequate control of extracranial disease. Surgical resection is recommended in patients with progressive systemic disease but good quality of life and symptoms caused by intracranial hypertension. Immediate evacuation can save the life of patients with subdural haematoma. Histopathological study can establish a diagnosis, especially in patients with known systemic primary disease.<a class="elsevierStyleCrossRefs" href="#bib0380"><span class="elsevierStyleSup">37,38</span></a> High doses of corticosteroids (dexamethasone) can cause temporary symptom relief.<a class="elsevierStyleCrossRef" href="#bib0385"><span class="elsevierStyleSup">38</span></a> Whole brain radiotherapy can be used as palliative therapy if the dural lesions are associated with parenchymal metastases, while radiosurgery is reserved for isolated lesions less than 3<span class="elsevierStyleHsp" style=""></span>cm in diameter.<a class="elsevierStyleCrossRefs" href="#bib0375"><span class="elsevierStyleSup">36,38</span></a></p></span><span id="sec0080" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Prognosis</span><p id="par0150" class="elsevierStylePara elsevierViewall">The prognosis of dural metastases can be extrapolated from the prognosis of brain metastases under 1 year of survival. Most patients die due to systemic disease complications before they die from neurological complications. Prognosis is most favourable for haematological neoplasms, breast and lung cancer, with a survival of 365, 273 and 120 days respectively.<a class="elsevierStyleCrossRefs" href="#bib0380"><span class="elsevierStyleSup">37,38</span></a></p></span><span id="sec0085" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Conclusions</span><p id="par0155" class="elsevierStylePara elsevierViewall">Although brain metastasis is not an uncommon condition worldwide, in Mexico there are no multidisciplinary programmes established to provide continuity for patients in whom the primary tumour has been identified, even though up to 40% of patients with systemic cancer have brain metastases. It should be noted that even after a thorough study, the primary tumour cannot be identified in 15% of brain metastasis patients. The most common types of neoplasm that present brain metastasis are lung cancer, breast cancer, melanoma, colorectal cancer and renal cancer. More reliable statistics must be established in Mexico in order to combat brain metastasis. Given the new therapy techniques (surgery, chemotherapy and radiotherapy) and increased survival, in patients in whom the primary tumour has been identified there is a possibility that the risk of brain metastasis may increase, and therefore continual review protocols must be diligently applied in these patients. This will help in the diagnosis and suitable management of these patients.</p></span><span id="sec0090" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Conflict of interest</span><p id="par0160" class="elsevierStylePara elsevierViewall">The authors declare that they have no conflict of interests.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:23 [ 0 => array:3 [ "identificador" => "xres800889" "titulo" => "Abstract" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0005" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec799297" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres800890" "titulo" => "Resumen" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0010" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec799298" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:2 [ "identificador" => "sec0010" "titulo" => "Clinical diagnosis" ] 6 => array:2 [ "identificador" => "sec0015" "titulo" => "Diagnostic imaging" ] 7 => array:2 [ "identificador" => "sec0020" "titulo" => "Stereotactic biopsy for the diagnosis of metastatic brain tumours" ] 8 => array:2 [ "identificador" => "sec0025" "titulo" => "RPA (recursive partitioning analysis) classification" ] 9 => array:2 [ "identificador" => "sec0030" "titulo" => "Treatment" ] 10 => array:2 [ "identificador" => "sec0035" "titulo" => "Surgery" ] 11 => array:2 [ "identificador" => "sec0040" "titulo" => "Radiotherapy" ] 12 => array:2 [ "identificador" => "sec0045" "titulo" => "Radiosurgery" ] 13 => array:2 [ "identificador" => "sec0050" "titulo" => "Chemotherapy" ] 14 => array:2 [ "identificador" => "sec0055" "titulo" => "Prognosis" ] 15 => array:2 [ "identificador" => "sec0060" "titulo" => "Dural metastases" ] 16 => array:2 [ "identificador" => "sec0065" "titulo" => "Clinical manifestations" ] 17 => array:2 [ "identificador" => "sec0070" "titulo" => "Diagnosis" ] 18 => array:2 [ "identificador" => "sec0075" "titulo" => "Treatment" ] 19 => array:2 [ "identificador" => "sec0080" "titulo" => "Prognosis" ] 20 => array:2 [ "identificador" => "sec0085" "titulo" => "Conclusions" ] 21 => array:2 [ "identificador" => "sec0090" "titulo" => "Conflict of interest" ] 22 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2015-10-29" "fechaAceptado" => "2016-04-29" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec799297" "palabras" => array:4 [ 0 => "Brain metastasis" 1 => "Chemotherapy" 2 => "Surgical resection" 3 => "Radiotherapy" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec799298" "palabras" => array:4 [ 0 => "Metástasis cerebral" 1 => "Quimioterapia" 2 => "Resección quirúrgica" 3 => "Radioterapia" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Brain metastases frequently occur secondary to poorly controlled primary lung, breast, melanoma, colorectal and renal tumours. Because of this, correct diagnosis and early treatment of brain metastasis is difficult, which is why the condition should be treated and controlled by a multidisciplinary medical team so as to obtain real-life and reliable statistics and to lower the incidence of brain metastasis, improving the quality of life of patients and reducing mortality rates.</p></span>" ] "es" => array:2 [ "titulo" => "Resumen" "resumen" => "<span id="abst0010" class="elsevierStyleSection elsevierViewall"><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">La enfermedad metastásica cerebral (EMC) es una patología, frecuente sobre todo en tumores primarios de pulmón, mama, melanoma, colorrectal y renal descontrolados. El diagnóstico oportuno y tratamiento temprano, es la falla sobre la EMC, debido a la misma causa. Por lo que debería ser manejado con un equipo médico multidisciplinario, para poder controlar, obtener estadísticas reales, y fidedignas, y así bajar la frecuencia de EMC, mejorando la calidad de vida de los pacientes, y reduciendo las estadísticas de mortalidad.</p></span>" ] ] "multimedia" => array:9 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1081 "Ancho" => 990 "Tamanyo" => 111198 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Axial cut of non-contrast CT brain scan showing an isodense image to the left frontal brain parenchyma marked with an arrow, as well as perilesional oedema corresponding to the hypodense image.</p>" ] ] 1 => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 816 "Ancho" => 1501 "Tamanyo" => 133739 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Axial cut of contrast MRI of the brain. On the left, T2-weighted image showing hyperintense left frontal region marked with arrows. On the right, T1-weighted image showing perilesional hypointensity and central hyperintensity of the left frontal region marked with arrows.</p>" ] ] 2 => array:7 [ "identificador" => "fig0015" "etiqueta" => "Figure 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 772 "Ancho" => 1500 "Tamanyo" => 125268 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Spectroscopy of right frontal lesion marked with arrows on the image to the left; and the image to the right marked with the arrow shows an increase in choline representing the accelerated formation of cell membranes compatible with metastatic lesion.</p>" ] ] 3 => array:7 [ "identificador" => "fig0020" "etiqueta" => "Figure 4" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr4.jpeg" "Alto" => 932 "Ancho" => 990 "Tamanyo" => 121806 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Stereotactic biopsy with ZD frame. Contrast-enhanced CAT image showing a thalamic tumour lesion, calculating coordinates for stereotactic-guided biopsy sampling.</p>" ] ] 4 => array:7 [ "identificador" => "fig0025" "etiqueta" => "Figure 5" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr5.jpeg" "Alto" => 881 "Ancho" => 1500 "Tamanyo" => 134852 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Magnetic resonance of the brain, T1-weighted sequence image with contrast. A shows the coronal cut and B the axial cut, with the presence of a hyperintense image in the right parietal–temporal–occipital with bone infiltration and displacement of brain parenchyma.</p>" ] ] 5 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Refs. <a class="elsevierStyleCrossRefs" href="#bib0245">10, 11</a>.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Primary tumour \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">% Metastasis (12) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">% Metastasis (13) \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Lungs \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">11,763/59,038 (19.9%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">156/938 (16.3%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Breasts \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2635/51,898 (5.1%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">42/802 (5.0%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Kidneys \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">467/7205 (6.5%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">12/114 (9.8%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Melanoma \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">566/8229 (6.9%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">12/150 (7.4%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Colorectal \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">779/42,817 (1.8%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">10/720 (1.2%) \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1343725.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Incidence of brain metastasis.</p>" ] ] 6 => array:8 [ "identificador" => "tbl0010" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at2" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Values in brackets represent percentage of symptoms.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td-with-role" title="table-head ; entry_with_role_rowhead " align="left" valign="top" scope="col">Clinical presentation \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " colspan="3" align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Number of patients</th></tr><tr title="table-row"><th class="td" title="table-head " align="" valign="top" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Primary tumour not identified \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Primary tumour identified \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Total \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Focal deficit \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">78 (64) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">108 (51) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">186 (56) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Seizures \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">22 (18) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">37 (17) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">59 (18) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Intracranial hypertension \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">10 (8) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">23 (11) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">33 (10) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Headache \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">7 (6) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">17 (8) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">24 (7) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Asymptomatic \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">4 (3) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">29 (14) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">33 (10) \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1343726.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Clinical manifestations in patients with brain metastasis (Neurosurg. Focus/Volume 22/March, 2007).</p>" ] ] 7 => array:8 [ "identificador" => "tbl0015" "etiqueta" => "Table 3" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at3" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">Ref. <a class="elsevierStyleCrossRef" href="#bib0355">33</a>.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Cancer \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Incidence % \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Prostate \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">19.5 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Breasts \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">16.5 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Lungs \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">11 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Gastric \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">7.5 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Unknown \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">9.5 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Haematological \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">6.3 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1343724.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Types of cancer spread to the dura mater<a class="elsevierStyleCrossRef" href="#bib0330"><span class="elsevierStyleSup">27</span></a></p>" ] ] 8 => array:8 [ "identificador" => "tbl0020" "etiqueta" => "Table 4" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at4" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spar0075" class="elsevierStyleSimplePara elsevierViewall">Ref. <a class="elsevierStyleCrossRef" href="#bib0355">33</a>.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="" valign="top" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">n</span> 89% \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Increased intracranial pressure \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">23.5% \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Neurological deficit \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">20% \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Coma \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">10% \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Cranial neuropathy \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">10% \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Seizures \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">9% \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Headache \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">7% \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Confusion \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">4.5% \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Asymptomatic \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">16% \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1343723.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">Signs and symptoms in patients with dural metastases<a class="elsevierStyleCrossRef" href="#bib0330"><span class="elsevierStyleSup">27</span></a></p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:39 [ 0 => array:3 [ "identificador" => "bib0200" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Management of brain metastases" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "J. Posner" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Rev Neurol" "fecha" => "1992" "volumen" => "148" "paginaInicial" => "477" "paginaFinal" => "487" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1448668" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0205" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:1 [ "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "J.B. Posner" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Libro" => array:5 [ "fecha" => "1995" "paginaInicial" => "353" "paginaFinal" => "385" "editorial" => "F.A. Davis" "editorialLocalizacion" => "Philadelphia" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0210" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Radiation therapy for brain metastasis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "J.G. Cairncross" 1 => "J.H. Kim" 2 => "J.B. Posner" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/ana.410070606" "Revista" => array:6 [ "tituloSerie" => "Ann Neurol" "fecha" => "1980" "volumen" => "7" "paginaInicial" => "529" "paginaFinal" => "541" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7436358" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0215" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Distribution of brain metastases" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "J.Y. Delattre" 1 => "G. Krol" 2 => "H.T. Thaler" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Arch Neurol" "fecha" => "1988" "volumen" => "45" "paginaInicial" => "741" "paginaFinal" => "744" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/3390029" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0220" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Epidemiology of brain metastases" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "P. Kehrli" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Neurochirurgie" "fecha" => "1999" "volumen" => "45" "paginaInicial" => "357" "paginaFinal" => "363" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10717583" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0225" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Demographics of brain metastasis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J.D. Johnson" 1 => "B. Young" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Neurosurg Clin N Am" "fecha" => "1996" "volumen" => "7" "numero" => "3" "paginaInicial" => "337" "paginaFinal" => "344" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8823767" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0230" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Brain metastases. Histology, multiplicity, surgery and survival" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "E.S. Nussbaum" 1 => "H.R. Djalilian" 2 => "K.H. Cho" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Cancer" "fecha" => "1996" "volumen" => "78" "paginaInicial" => "1781" "paginaFinal" => "1788" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8859192" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0235" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Brain metastases" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A.B. Lassman" 1 => "L.M. De Angelis" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Neurol Clin" "fecha" => "2003" "volumen" => "21" "numero" => "1" "paginaInicial" => "1" "paginaFinal" => "23" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12690643" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0240" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intracranial metastases from systemic cancer" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J.B. Posner" 1 => "N.L. Chernik" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Adv Neurol" "fecha" => "1978" "volumen" => "19" "paginaInicial" => "575" "paginaFinal" => "587" ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0245" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan Detroit cancer surveillance system" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "J.S. Barnholtz-Sloan" 1 => "A.E. Sloan" 2 => "P. Lai" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1200/JCO.2004.12.149" "Revista" => array:7 [ "tituloSerie" => "J Clin Oncol" "fecha" => "2004" "volumen" => "22" "numero" => "14" "paginaInicial" => "2865" "paginaFinal" => "2872" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15254054" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0250" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "L.J. Schouten" 1 => "J. Rutten" 2 => "H.A.M. Huveneers" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Cancer" "fecha" => "2002" "volumen" => "94" "numero" => "10" "paginaInicial" => "2698" "paginaFinal" => "2705" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12173339" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0255" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Brain metastasis of unknown primary: a diagnostic and therapeutic dilemma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "K.S. Polyzoidis" 1 => "G. Miliaras" 2 => "N. Pavlidis" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ctrv.2005.03.006" "Revista" => array:6 [ "tituloSerie" => "Cancer Treat Rev" "fecha" => "2005" "volumen" => "31" "paginaInicial" => "247" "paginaFinal" => "255" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15913895" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0260" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The spectrum of neurological disease in patients with systemic cancer" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "P.D. Clouston" 1 => "L.M. De Angelis" 2 => "J.B. Posner" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/ana.410310307" "Revista" => array:7 [ "tituloSerie" => "Ann Neurol" "fecha" => "1992" "volumen" => "31" "numero" => "3" "paginaInicial" => "268" "paginaFinal" => "273" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1637135" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0265" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prognostic factors derived from recursive partition analysis (RPA) of Radiation Therapy Oncology Group (RTOG) brain metastases trials applied to surgically resected and irradiated brain metastatic cases" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "O. Agboola" 1 => "B. Benoit" 2 => "P. Cross" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Int J Radiat Oncol Biol Phys" "fecha" => "1998" "volumen" => "42" "paginaInicial" => "155" "paginaFinal" => "159" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9747833" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0270" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diagnosis of cerebral metastasis: double-dose delayed CT vs contrast-enhanced MR imaging" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "P.C. Davis" 1 => "P.A. Hudgins" 2 => "S.B. Peterman" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Am J Neuroradiol" "fecha" => "1991" "volumen" => "12" "paginaInicial" => "293" "paginaFinal" => "300" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1902031" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0275" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diagnostic accuracy of MRI compared to CC in patients with brain metastases" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "P.D. Schellinger" 1 => "H.M. Meinck" 2 => "A. Thron" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Neurooncol" "fecha" => "1999" "volumen" => "44" "paginaInicial" => "275" "paginaFinal" => "281" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10720207" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0280" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Fast spin echo MR imaging" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "S. Partovi" 1 => "E.K. Fram" 2 => "J.P. Karis" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Neuroimaging Clin N Am" "fecha" => "1999" "volumen" => "9" "numero" => "3" "paginaInicial" => "553" "paginaFinal" => "576" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10433645" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0285" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Inverse correlation between choline magnetic resonances spectroscopy signal intensity and the apparent diffusion coefficient in human glioma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "R.K. Gupta" 1 => "U. Sinha" 2 => "T.F. Cloughesy" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Magn Reson Med" "fecha" => "1999" "volumen" => "41" "numero" => "1" "paginaInicial" => "2" "paginaFinal" => "7" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10025604" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0290" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "M. Law" 1 => "S. Cha" 2 => "E.A. Knopp" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1148/radiol.2223010558" "Revista" => array:7 [ "tituloSerie" => "Radiology" "fecha" => "2002" "volumen" => "222" "numero" => "3" "paginaInicial" => "715" "paginaFinal" => "721" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11867790" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0295" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Single-photon emission computed tomography/computed tomography in brain tumors" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "O. Schillaci" 1 => "L. Filippi" 2 => "C. Manni" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1053/j.semnuclmed.2006.08.003" "Revista" => array:6 [ "tituloSerie" => "Semin Nucl Med" "fecha" => "2007" "volumen" => "37" "paginaInicial" => "34" "paginaFinal" => "47" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17161038" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0300" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparative evaluation of Tl-201 SPECT and CT in the follow-up of irradiated brain tumors" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "N.R. Datta" 1 => "R. Pasricha" 2 => "S. Gambhir" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Int J Clin Oncol" "fecha" => "2004" "volumen" => "9" "paginaInicial" => "51" "paginaFinal" => "58" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15162827" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0305" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Brain metastases detection on MR by means of three-dimensional tumor-appearance template matching" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "U. Pérez-Ramírez" 1 => "E. Arana" 2 => "D. Moratal" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:2 [ "tituloSerie" => "J Magn Reson Imaging" "fecha" => "2016" ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0310" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "L. Gaspar" 1 => "C. Scott" 2 => "M. Rotman" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Int J Radiat Oncol Biol Phys" "fecha" => "1997" "volumen" => "37" "paginaInicial" => "745" "paginaFinal" => "751" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9128946" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0315" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The role of prophylactic anticonvulsants in the management of brain metastases: a systematic review and evidence-based clinical practice guideline" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "T. Mikkelsen" 1 => "N.A. Paleologos" 2 => "P.D. Robinson" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Neurooncol" "fecha" => "2010" "volumen" => "96" "numero" => "1" "paginaInicial" => "97e102" ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0320" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "T.C. Ryken" 1 => "M. McDermott" 2 => "P.D. Robinson" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s11060-009-0057-4" "Revista" => array:7 [ "tituloSerie" => "J Neurooncol" "fecha" => "2010" "volumen" => "96" "numero" => "1" "paginaInicial" => "103" "paginaFinal" => "114" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19957014" "web" => "Medline" ] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0325" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Single brain metastases from unknown primary malignancies in CT-era" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "M. Salvati" 1 => "L. Cervoni" 2 => "A. Raco" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Neurooncol" "fecha" => "1995" "volumen" => "23" "paginaInicial" => "75" "paginaFinal" => "80" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7623072" "web" => "Medline" ] ] ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0330" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A randomized trial of surgery in the treatment of single brain metastases to the brain: a randomized trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "R.A. Patchell" 1 => "P.A. Tibbs" 2 => "J.W. Walsh" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJM199002223220802" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "1990" "volumen" => "322" "paginaInicial" => "494" "paginaFinal" => "500" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/2405271" "web" => "Medline" ] ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0335" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Current therapeutic approaches in patients with brain metastases" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "K.H. Peacock" 1 => "G.J. Lesser" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Curr Treat Options Oncol" "fecha" => "2006" "volumen" => "7" "paginaInicial" => "479" "paginaFinal" => "489" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17032560" "web" => "Medline" ] ] ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0340" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Surgical treatment of multiple brain metastases" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "R.K. Bindal" 1 => "R. Sawaya" 2 => "M.E. Leavens" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3171/jns.1993.79.2.0210" "Revista" => array:6 [ "tituloSerie" => "J Neurosurg" "fecha" => "1993" "volumen" => "79" "paginaInicial" => "210" "paginaFinal" => "216" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8331402" "web" => "Medline" ] ] ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0345" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Thromboembolic phenomena in neurosurgical patients operated upon for primary and metastatic brain tumors" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "S. Constantini" 1 => "R. Kornowski" 2 => "S. Pomeranz" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Acta Neurochir (Wien)" "fecha" => "1991" "volumen" => "109" "paginaInicial" => "93" "paginaFinal" => "97" ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0350" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Chronic disseminated intravascular coagulation and metastatic brain tumor: a case report and review of the literature" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "R. Sawaya" 1 => "J.A. Donlon" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Neurosurgery" "fecha" => "1983" "volumen" => "12" "paginaInicial" => "580" "paginaFinal" => "584" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/6866245" "web" => "Medline" ] ] ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib0355" "etiqueta" => "32" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Current treatment approaches to surgery for brain metastases" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "A.K. Sills" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Neurosurgery" "fecha" => "2005" "volumen" => "57" "numero" => "5" "paginaInicial" => "S24" "paginaFinal" => "S32" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16237284" "web" => "Medline" ] ] ] ] ] ] ] ] 32 => array:3 [ "identificador" => "bib0360" "etiqueta" => "33" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Dural metastases in prostate cancer" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A.M. Bentley" 1 => "J.C. Keen" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Clin Oncol (R Coll Radiol)" "fecha" => "2003" "volumen" => "15" "numero" => "3" "paginaInicial" => "165" "paginaFinal" => "166" ] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib0365" "etiqueta" => "34" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diagnosis and management of central nervous system metastases from breast cancer" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "E.L. Chang" 1 => "S. Lo" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Oncologist" "fecha" => "2003" "volumen" => "8" "numero" => "5" "paginaInicial" => "398" "paginaFinal" => "410" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14530493" "web" => "Medline" ] ] ] ] ] ] ] ] 34 => array:3 [ "identificador" => "bib0370" "etiqueta" => "35" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Whole brain radiotherapy in the management of brain metastasis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "D. Khuntia" 1 => "P. Brown" 2 => "J. Li" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1200/JCO.2005.04.6185" "Revista" => array:7 [ "tituloSerie" => "J Clin Oncol" "fecha" => "2006" "volumen" => "24" "numero" => "8" "paginaInicial" => "1295" "paginaFinal" => "1304" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16525185" "web" => "Medline" ] ] ] ] ] ] ] ] 35 => array:3 [ "identificador" => "bib0375" "etiqueta" => "36" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cerebral metastases a therapeutic update" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "R. Cavaliere" 1 => "D. Schiff" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/ncpneuro0263" "Revista" => array:7 [ "tituloSerie" => "Nat Clin Pract Neurol" "fecha" => "2006" "volumen" => "2" "numero" => "8" "paginaInicial" => "426" "paginaFinal" => "436" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16932601" "web" => "Medline" ] ] ] ] ] ] ] ] 36 => array:3 [ "identificador" => "bib0380" "etiqueta" => "37" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "L.E. Gaspar" 1 => "C. Scott" 2 => "K. Murray" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Int J Radiat Oncol Biol Phys" "fecha" => "2000" "volumen" => "47" "numero" => "4" "paginaInicial" => "1001" "paginaFinal" => "1006" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10863071" "web" => "Medline" ] ] ] ] ] ] ] ] 37 => array:3 [ "identificador" => "bib0385" "etiqueta" => "38" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Skull and dural metastases" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "B.P.W. Jansen" 1 => "P.A.E. Sillevis Smitt" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:4 [ "titulo" => "Cancer neurology in clinical practice" "paginaInicial" => "87" "paginaFinal" => "92" "serieFecha" => "2002" ] ] ] ] ] ] 38 => array:3 [ "identificador" => "bib0390" "etiqueta" => "39" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Current perspective. The role of chemotherapy in brain metastases" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "M.J. Van den Bent" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Eur J Cancer" "fecha" => "2003" "volumen" => "39" "paginaInicial" => "2114" "paginaFinal" => "2120" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14522368" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/01851063/0000008000000001/v2_201702120003/S0185106316300166/v2_201702120003/en/main.assets" "Apartado" => array:4 [ "identificador" => "46400" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Review articles" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/01851063/0000008000000001/v2_201702120003/S0185106316300166/v2_201702120003/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0185106316300166?idApp=UINPBA00004N" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 October | 125 | 16 | 141 |
2024 September | 231 | 44 | 275 |
2024 August | 270 | 40 | 310 |
2024 July | 262 | 57 | 319 |
2024 June | 213 | 47 | 260 |
2024 May | 215 | 47 | 262 |
2024 April | 232 | 36 | 268 |
2024 March | 242 | 38 | 280 |
2024 February | 258 | 66 | 324 |
2024 January | 365 | 68 | 433 |
2023 December | 250 | 59 | 309 |
2023 November | 386 | 78 | 464 |
2023 October | 385 | 89 | 474 |
2023 September | 288 | 71 | 359 |
2023 August | 221 | 47 | 268 |
2023 July | 182 | 43 | 225 |
2023 June | 199 | 47 | 246 |
2023 May | 194 | 38 | 232 |
2023 April | 216 | 51 | 267 |
2023 March | 262 | 48 | 310 |
2023 February | 210 | 26 | 236 |
2023 January | 135 | 7 | 142 |
2022 December | 111 | 12 | 123 |
2022 November | 130 | 23 | 153 |
2022 October | 150 | 32 | 182 |
2022 September | 154 | 27 | 181 |
2022 August | 166 | 49 | 215 |
2022 July | 177 | 38 | 215 |
2022 June | 135 | 31 | 166 |
2022 May | 151 | 29 | 180 |
2022 April | 180 | 36 | 216 |
2022 March | 185 | 25 | 210 |
2022 February | 240 | 36 | 276 |
2022 January | 277 | 52 | 329 |
2021 December | 179 | 27 | 206 |
2021 November | 156 | 25 | 181 |
2021 October | 141 | 40 | 181 |
2021 September | 138 | 30 | 168 |
2021 August | 141 | 22 | 163 |
2021 July | 91 | 20 | 111 |
2021 June | 161 | 29 | 190 |
2021 May | 176 | 17 | 193 |
2021 April | 386 | 79 | 465 |
2021 March | 268 | 51 | 319 |
2021 February | 137 | 34 | 171 |
2021 January | 160 | 47 | 207 |
2020 December | 143 | 32 | 175 |
2020 November | 126 | 23 | 149 |
2020 October | 78 | 15 | 93 |
2020 September | 97 | 23 | 120 |
2020 August | 99 | 24 | 123 |
2020 July | 79 | 21 | 100 |
2020 June | 89 | 13 | 102 |
2020 May | 85 | 21 | 106 |
2020 April | 72 | 27 | 99 |
2020 March | 78 | 11 | 89 |
2020 February | 105 | 20 | 125 |
2020 January | 97 | 16 | 113 |
2019 December | 84 | 19 | 103 |
2019 November | 54 | 7 | 61 |
2019 October | 54 | 12 | 66 |
2019 September | 42 | 9 | 51 |
2019 August | 30 | 3 | 33 |
2019 July | 34 | 17 | 51 |
2019 June | 81 | 2 | 83 |
2019 May | 111 | 5 | 116 |
2019 April | 77 | 1 | 78 |
2019 March | 15 | 8 | 23 |
2019 February | 21 | 3 | 24 |
2019 January | 23 | 6 | 29 |
2018 December | 22 | 7 | 29 |
2018 November | 29 | 7 | 36 |
2018 October | 42 | 7 | 49 |
2018 September | 83 | 8 | 91 |
2018 August | 62 | 10 | 72 |
2018 July | 37 | 7 | 44 |
2018 June | 30 | 12 | 42 |
2018 May | 67 | 18 | 85 |
2018 April | 40 | 9 | 49 |
2018 March | 27 | 2 | 29 |
2018 February | 28 | 2 | 30 |
2018 January | 16 | 1 | 17 |
2017 December | 18 | 2 | 20 |
2017 November | 24 | 2 | 26 |
2017 October | 21 | 4 | 25 |
2017 September | 22 | 4 | 26 |
2017 August | 27 | 3 | 30 |
2017 July | 28 | 2 | 30 |
2017 June | 40 | 19 | 59 |
2017 May | 53 | 1 | 54 |
2017 April | 54 | 6 | 60 |
2017 March | 66 | 40 | 106 |
2017 February | 62 | 11 | 73 |
2017 January | 4 | 3 | 7 |
2016 December | 0 | 6 | 6 |
2016 November | 0 | 5 | 5 |
2016 October | 5 | 10 | 15 |
2016 September | 0 | 6 | 6 |
2016 August | 2 | 4 | 6 |
2016 July | 1 | 2 | 3 |